Novo Nordisk's new CagriSema obesity drug trial to begin on Feb. 10, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, ...
The FDA’s new, same-old food labels demand better obesity solutions
All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
Biocon's Q3 revenue dips; banks on obesity drugs for future growth
Indian biopharma company Biocon reported third-quarter revenue on Thursday that fell about 3% when compared with the year-earlier period, which included revenue from its domestic branded formulation ...
Novo Nordisk will test CagriSema's long-term efficacy in late-stage trial, clinicaltrials.gov entry shows
Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.
A cautionary tale that Europe can’t afford to ignore
It’s a problem that has plagued European governments for decades, from the credit-crunch bank bailouts of 2008 to more recent ...
About Half Of Americans Approve Of Using Weight-Loss Drugs To Treat Obesity, Ap-Norc Poll Finds
A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think about weight-loss drugs like Ozempic or Wegovy. (AP Video: Laura Bargfeld) ...
STAT16h
RFK Jr., Trump’s HHS pick, interrogated on vaccine views at second confirmation hearing
RFK Jr.'s confirmation hearings continue today as he appears before a second Senate committee. Follow STAT's live updates.
STAT6h
Novo Nordisk
For more on the business and cultural impact of new weight loss drugs, see our special series The Obesity Revolution.
The high cost of weight loss: How patients are fighting for access to breakthrough medications
CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
Investors Chronicle19h
A pharma stock emerging from Novo Nordisk's shadow
Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB (BE:UCB) in 2023, while Joerg Hornstein has been in post as chief finance ...
RFK Jr. on defensive over his vaccine views as a key confirmation vote hangs in the balance
Robert F. Kennedy, Jr., President Trump's nominee to serve as Secretary of Health and Human Services testifies during a ...
US Supreme Court rejects likely final appeal of South Carolina inmate a day before his execution
The U.S. Supreme Court rejected Thursday what is likely the final appeal of a South Carolina inmate the day before his ...